Sign inJoin waitlistJoin the waitlist

Eugene Koay

Scientific Director · University of Texas M D Anderson Cancer Center

Credentials: · · · ·

History

University of Texas M D Anderson Cancer Center
Present
University of Texas M D Anderson Cancer Center
Present
University of Texas M D Anderson Cancer Center
Present

Radiation Oncology
University of Texas M D Anderson Cancer Center
2009–2014
Rice University
Baylor College of Medicine
2005–2009
Rice University
2001–2005

Research

Early Detection of Pancreatic Cancer: Opportunities and Challenges
Review · Gastroenterology · 2019 · 634 citations
Early detection of pancreatic cancer
Review · The Lancet. Gastroenterology & hepatology · 2020 · 366 citations
Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer
Gastroenterology · 2019 · 303 citations

Prajnan Das
75 papers
Ethan Ludmir
55 papers · 8 as a resident
Albert Koong
54 papers
Bruce Minsky
54 papers
Emma Holliday
54 papers · 2 as a resident
CT
Cullen Taniguchi
53 papers
Matthew Katz
51 papers
Grace Smith
45 papers
Robert Wolff
43 papers
Anirban Maitra
42 papers
JH
Joseph Herman
38 papers
Milind Javle
38 papers

Grants

Circulating Biomarkers and Imaging for Early Detection of Pancreatic Cancer
National Cancer Institute · U01
PI · $2.8M · University of Tx Md Anderson Can Ctr
2018–2029
Risk Stratification for and Early Detection of Liver Cancer
National Cancer Institute · U01
PI · $3M · Baylor College of Medicine
2018–2028
Early Detection of Hepatocellular Carcinoma
National Cancer Institute · R01
PI · $3.3M · University of Tx Md Anderson Can Ctr
2016–2027

Clinical trials

HYPERION CCA: a Phase 2 Trial of Systemic Therapy With or Without Liver-directed Radiation Therapy for Patients With Advanced Intrahepatic Cholangiocarcinoma
Principal investigator · Recruiting · Phase 2
M.D. Anderson Cancer Center
2025–2030
New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study
Principal investigator · Withdrawn · Phase 2
M.D. Anderson Cancer Center
2023–2026
Hypofractionated Radiation Therapy and Bintrafusp Alfa for the Treatment of Advanced Intrahepatic Cholangiocarcinoma
Principal investigator · Active not recruiting · Phase 1
M.D. Anderson Cancer Center
2021–2027
NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer
Principal investigator · Active not recruiting · Phase 1
M.D. Anderson Cancer Center
2020–2026